MXCT Financials
MaxCyte Inc - Financial statements & key metrics
Stock Price
$1.22
Market Cap
$124.26M
P/E Ratio
-3.1
EPS
$-0.43
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$38.63M
Gross Profit
-
Operating Income
-
Net Income
$-41.05M
EPS (Diluted)
$-0.39
Balance Sheet Highlights
Total Assets
$239.47M
Total Liabilities
$33.22M
Shareholders Equity
-
Cash & Equivalents
$27.88M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-27.61M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-162.4%
Net Margin
-132.6%
ROE
-23.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MXCT revenue?
MXCT's most recent quarterly revenue was $38.63M. Annual revenue can be calculated by summing the four most recent quarters.
Is MXCT profitable?
MXCT reported a loss of $41.05M in the most recent quarter. The net profit margin is -132.6%.
What is MXCT market cap?
MXCT has a market capitalization of $124.26M, making it a small-cap stock.
Does MXCT have debt?
View MXCT's balance sheet for debt information.
What is MXCT cash flow?
Cash flow data is available in the full financial statements.